Invention Grant
- Patent Title: Deuterated tryptamine derivatives and methods of use
-
Application No.: US18353492Application Date: 2023-07-17
-
Publication No.: US12110272B2Publication Date: 2024-10-08
- Inventor: Alex Nivorozhkin , Michael Palfreyman
- Applicant: CYBIN IRL LIMITED
- Applicant Address: IE Dublin
- Assignee: Cybin IRL Limited
- Current Assignee: Cybin IRL Limited
- Current Assignee Address: IE Dublin
- Agency: Lathrop GPM LLP
- Agent Lisa Hillman
- Main IPC: C07D209/16
- IPC: C07D209/16 ; A61K9/20 ; A61K31/4045
Abstract:
The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with a serotonin 5-HT2 receptor.
Public/Granted literature
- US20230357147A1 DEUTERATED TRYPTAMINE DERIVATIVES AND METHODS OF USE Public/Granted day:2023-11-09
Information query
